Small molecules & peptides
DOTA-TATE acetate
Precursor for radiolabelled DOTA-[Tyr³]octreotate
DOTA-[Tyr3]-Octreotate, DOTA-[Tyr3, Thr8]-Octreotide
DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH, cyclic disulfide; DOTA = N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-; Supplied as acetate salt
Quality
Research Chemical
Characteristics
Molar mass 1435.63
CAS RN [177943-89-4]
Purity ≥ 97 %
- Colorless to off-white freeze-dried solid
Certificates
CoA: appearance, MS (identity), HPLC (purity)
Literature
De Jong M. et al. Combination Radionuclide Therapy Using ¹⁷⁷Lu- and ⁹⁰Y-Labeled Somatostatin Analogs. J. Nucl. Med., 2005, 46,13S.
Valkema R. et al. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with ⁹⁰Y-DOTA⁰,Tyr³-Octreotide and ¹⁷⁷Lu-DOTA⁰,Tyr³-Octreotate. J. Nucl. Med. 2005, 46, 8.
Add to inquiry
| Product | Product No. | Filling amount | Quantity | ||
|---|---|---|---|---|---|
| /products/small-molecules-and-peptides/chemical/4b620a41-6d05-4cde-8a4d-b1678f371da1 | Chemicals | Product No.: 9770 | Filling amount: 1 mg | ||
| /products/small-molecules-and-peptides/chemical/4b620a41-6d05-4cde-8a4d-b1678f371da1 | Chemicals | Product No.: 9770 | Filling amount: 10 mg | ||
| /products/small-molecules-and-peptides/chemical/4b620a41-6d05-4cde-8a4d-b1678f371da1 | Chemicals | Product No.: 9770 |
Product was added